LRRK2 and Parkinson disease: Increased LRRK2 activity may increase susceptibility to gut inflammation and then induce systemic inflammation, finally lead to PD development; LRRK2 may induce pathogenic α-synuclein in gut by mediating immune response, leading to neurodegeneration.